Ginkgo Bioworks Inc. (DNA)
NYSE: DNA
· Real-Time Price · USD
11.49
0.24 (2.13%)
At close: Sep 26, 2025, 3:59 PM
11.47
-0.22%
After-hours: Sep 26, 2025, 07:31 PM EDT
Ginkgo Bioworks Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service Revenue | 10.47M | 10.09M | 39.11M | 13.96M | 20M | 10.05M | 19.54M | 11.76M | 24.5M | 34.94M | 32.6M | 36.53M | 96.49M | 132.97M | 105.92M | 34.38M |
| Service Revenue Growth | +3.79% | -74.21% | +180.25% | -30.22% | +98.92% | -48.54% | +66.15% | -52.00% | -29.89% | +7.19% | -10.76% | -62.14% | -27.44% | +25.54% | +208.08% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 43.28M | 49.04M | 57.3M | 52.29M | 66.28M | 51.02M | 65.56M | 82.03M | 102.34M | 111.43M | 121.42M | 435.18M | 438.43M | 434.77M | 781.63M | 28.96M | 34.44M | 17.93M | 12.91M | 9.88M | 8.95M | 6.57M |
| Selling, General, and Administrative Revenue Growth | -11.75% | -14.41% | +9.57% | -21.11% | +29.91% | -22.18% | -20.08% | -19.85% | -8.16% | -8.23% | -72.10% | -0.74% | +0.84% | -44.38% | +2599.08% | -15.91% | +92.11% | +38.83% | +30.75% | +10.36% | +36.25% | n/a |
| Research and Development Revenue | 53.37M | 70.92M | 76.38M | 77.01M | 134.22M | 123.59M | 107.7M | 156.66M | 144.28M | 162.64M | 181.16M | 259.58M | 289.19M | 322.72M | 985.02M | 53.02M | 52.03M | 59.59M | 61.19M | 36.07M | 32.27M | 30.24M |
| Research and Development Revenue Growth | -24.75% | -7.14% | -0.82% | -42.63% | +8.60% | +14.75% | -31.25% | +8.58% | -11.29% | -10.22% | -30.21% | -10.24% | -10.39% | -67.24% | +1757.80% | +1.90% | -12.68% | -2.62% | +69.65% | +11.78% | +6.73% | n/a |